ArticleScientific reports2025
Outcomes of pneumatic retinopexy for primary rhegmatogenous retinal detachment in a Japanese cohort.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to evaluate 12-month outcomes of pneumatic retinopexy (PnR) for primary rhegmatogenous retinal detachment (RRD) in a Japanese population. This multicenter, retrospective study included 54 eyes treated with PnR between December 2020 and March 2024. Primary anatomical reattachment rate (PARR) and best-corrected visual acuity (BCVA) were assessed. Inclusion criteria were similar with those utilized in PIVOT trials. PARR was analyzed for all cases, for eyes with a single break, and by break location: superior (10-2 o'clock), superior and inferior (10-2 and 4-8 o'clock; inferior breaks in the attached retina), and lateral/nasal (8-10 or 2-4 o'clock). BCVA (logMAR) significantly improved from 0.28 ± 0.63 preoperatively to 0.01 ± 0.21 at 6 months (p < 0.01) and - 0.00 ± 0.22 at 12 months (p < 0.01). The overall PARR was 94.4% (51/54 eyes), with higher success for eyes with a single break (97.2%) and horizontal breaks (100%), except for eyes with superior and inferior breaks (75%). Failures (n = 3) were due to redetachment from the same break (n = 2) or new break formation (n = 1), all of which were successfully treated with vitrectomy. With appropriate case selection, PnR may be effective for treating RRD in the Japanese population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.